Last updated 2026-07-23
Total raised
—
Stage
Mature
Founded
1965
Headcount
567
HQ
Yokne'am Illit, Israel
Sector
Health Tech & Life Sciences
About
Dexcel Pharma is a pharmaceutical company engaged in the discovery, development, manufacture, and commercialization of innovative pharmaceutical products based on its proprietary controlled-release technologies. Dexcel Pharma develops novel formulations of existing molecules for large therapeutic markets. The companys aim is to provide meaningful clinical benefits for patients with chronic diseases. For example, the companys PerioChip product offers a new approach to treating gum disease by using a small chip inserted under the gums. Dexcel Pharmas development pipeline includes more than 30 novel 505(b)2 formulations and complex generics, targeting markets in the U.S. and the EU.
Headcount over time
567 employees (2026-09) · 1 point
Offices
Yokne'am Illit, Israel · HQ / main office
Show all offices (5 more)
- Alzenau, Germany
- United Kingdom
- Singapore, Singapore
- Or Akiva, Israel
- Jerusalem, Israel
Q&A
- What is Dexcel Pharma's primary focus?
- Dexcel Pharma specializes in the discovery, development, manufacture, and commercialization of innovative pharmaceutical products, particularly focusing on new formulations of known molecules and complex generic drugs using proprietary controlled-release technologies.
- When was Dexcel Pharma founded?
- Dexcel Pharma was founded in January 1965.
- Where is Dexcel Pharma headquartered?
- Dexcel Pharma is headquartered in Yokne'am Illit, Israel.
- What is an example of a product developed by Dexcel Pharma?
- An example is PerioChip, a product that offers a new approach to treating gum disease by using a small chip inserted under the gums.
- How many employees does Dexcel Pharma have?
- Dexcel Pharma has 500+ employees.
- What markets does Dexcel Pharma target with its development pipeline?
- Dexcel Pharma's development pipeline, which includes over 30 novel 505(b)2 formulations and complex generics, targets markets in the U.S. and the EU.
- What is Dexcel Pharma's current stage according to startupim data?
- According to startupim data, Dexcel Pharma is currently in the 'Mature' stage.
- Does Dexcel Pharma have international offices?
- Yes, Dexcel Pharma has offices in Germany, the United Kingdom, and Singapore, in addition to multiple locations in Israel.
Team · 24
Dan Oren
Founder · Founder & Executive Chairman
Uri Oren
Co-Chief Executive Officer
Ilan Oren
Co-Chief Executive Officer
Eyal Dayan
VP, Research & Development
Yaron Erez
VP, Chief Financial Officer
Tamar Galanty
VP, Head of Quality
Jonathan Grushka
VP, General Counsel
Ran Kreshtino
VP, General Manager, Dexcel Pharma Israel
Miri Peleg
VP, Chief Information Officer
Amit Rotem
VP, Human Resources
Ygal Seelenfreund
VP, Sales & Marketing, International
Ziv Teresh
VP, Chief Operating Officer
Itamar Yaron-Enden
VP, Business Development
Douglas Boothe
Chief Executive Officer, Dexcel Pharma USA
Itamar Ben-Anat
Senior Vice President, Chief Operating Officer, Dexcel Pharma USA
Daniel G. Worley Jr.
Senior Vice President, Business Development & General Counsel, Dexcel Pharma USA
Barry Rogers
Vice President, Sales and Training, Dexcel Pharma USA
Enis Otuk
Managing Director, Dexcel Pharma UK
Craig Millard
Director of Finance, HR & Supply Chain, Dexcel Pharma UK
Neil Cook
Head of Sales, Dexcel Pharma UK
Julia Wilkinson
Head of Supply Chain, Dexcel Pharma UK
Nichola Johnston
Head of Quality and Qualified Person, Dexcel Pharma UK
Claire Webster
Principal and UK Qualified Person for Pharmacovigilance, Dexcel Pharma UK
Nivedita Valentine
Head of Business Development, Dexcel Pharma UK
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue EngineeringDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsBiotechnologyMedical Devices IndustryMedical ProductsHealthcarePatients
Business model
B2CB2B
Tags
sustained-releasegeneric-drugspharmaceuticalsdrug-discoverynanotechnologypharma-companiesdrug-deliverypatients
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
Identifiers & details
| Legal name | Dexcel Pharma Technologies Ltd. |
|---|---|
| Founded | 1965-1 |
| Employees (exact) | 567 |
| Offices | Alzenau; United Kingdom; Singapore; Or Akiva; Jerusalem |
| Wikidata QID | Q25491342 |
Radar intelligence
Patents
| EPO | 43 |
|---|
Web history (Wayback)
| Domain | dexcel.com |
|---|
Wikidata
| QID | Q25491342 |
|---|
Certificate / subdomain footprint
| Subdomains | 19 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 520043084 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 1988-03-22 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 4 — charge (2), annual_report (2) |
| Registered address | הקידמה 10 יקנעם עילית |
Recent registry events
| Date | Event |
|---|---|
| 2025-12-24 | סילוק שעבוד |
| 2026-01-06 | רישום שעבוד |
| 2026-02-02 | דו~ח שנתי-הוספת בעל תפקיד |
| 2026-02-02 | דו~ח שנתי-הסרת בעל תפקיד |